U
Medite Cancer Diagnostics, Inc. MDIT
$0.00 $0.000.00%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--

09/30/2018 06/30/2018 03/31/2018 12/31/2017 09/30/2017
Net Income -30.55% 59.84% 46.61% -63.61% 1.23%
Total Depreciation and Amortization -8.82% -4.23% -11.25% -27.27% 103.70%
Total Amortization of Deferred Charges 30.93% 33.33% 39.37% 1,714.29% --
Total Other Non-Cash Items 0.00% -2.33% -66.67% -62.82% 114.20%
Change in Net Operating Assets 37.47% -50.57% -192.01% -15.04% 2.42%
Cash from Operations 19.11% 38.15% 4.26% -270.19% 38.02%
Capital Expenditure -450.00% 0.00% 97.80% -468.75% -45.45%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -450.00% 0.00% 97.80% -468.75% -45.45%
Total Debt Issued 0.00% -36.48% 363.29% -93.23% 58,462.50%
Total Debt Repaid 27.91% -19.44% 92.65% 81.23% -1,584.52%
Issuance of Common Stock -- -- -- -41.38% -65.63%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 1.35% -37.89% 821.21% -108.33% 210.72%
Foreign Exchange rate Adjustments 94.29% -25.00% -106.64% 261.69% -294.78%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 139.39% 32.10% 84.63% -196.58% 1,060.99%
Weiss Ratings